A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis (MS-BMD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01811290|
Recruitment Status : Unknown
Verified January 2018 by Virginia I. Simnad, MD, Simnad, Virginia, M.D..
Recruitment status was: Active, not recruiting
First Posted : March 14, 2013
Last Update Posted : February 1, 2018
Simnad, Virginia, M.D.
Information provided by (Responsible Party):
Virginia I. Simnad, MD, Simnad, Virginia, M.D.
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||July 2018|
|Estimated Study Completion Date :||December 2018|